Yueyang Xing Long "net chat" dispel investors ' doubts

Seeking to attract capital to quicken the industrialization of "gastropathy vaccine" yesterday, Yueyang Hing Long Chairman Hou Yong led the management of relevant personnel and the company's shareholder reform sponsor, and investors on the internet for stomach vaccine industrialization of the introduction of strategic investor Program Exchange. Since 2000, Yueyang Hing Long committed to the "oral recombinant Helicobacter pylori vaccine" research through Chongqing Kang Wei, lasted 9 years, invested more than 30 million yuan, finally April 13 this year to obtain a new drug certificate.　　Originally a happy thing, but because a paper announcement makes Yueyang Hing long and small shareholder contradictions quickly intensified, also will the company to the forefront of public opinion. April 28, 2009, Yueyang Hing Long announced the annual report, but also in the 11th session of the Board of Directors of the 22nd meeting resolution Bulletin, "on the Chongqing Kang Wei follow-up operation of the resolution." The company shareholders on the Yueyang Hing long move is difficult to accept, May 11, 2009, and received 45 shareholders trustee Ishaoming submitted by the "small shareholder rights of special proposal", the market attention to a sharp rise. Investors question why such a project company, which has nurtured 9 years of hope for all its shareholders, is quitting?　　After the Yueyang Hing long consecutive announcement to explain, but investors to explain the reasons not recognized, which led to yesterday's Yueyang Hing Long management and investors online exchange. The atmosphere of the exchange is enthusiastic, investors have raised more than 1000 questions, Yueyang Xing Long management answered 120 core questions. In order to meet the investor's request, the meeting time extends 10 minutes.　　Through exchanges, Yueyang Hing Long management and related investors reached a preliminary consensus on the introduction of strategic investors and other matters, Yueyang Hing Long will be at any time to maintain communication with investors. Hou Yong Chairman said, "The introduction of strategic investors just to make the disease vaccine industry better, there is no company's interests beyond anything." At the same time as a business manager, hope to be able to get the majority of shareholders understanding and support. "Hou Yong said:" Chongqing Kang Wei finally obtained a new drug certificate for vaccine products, this is our 9 years of hard waiting for the result, the introduction of strategic investors does not mean to give up, at least currently has not considered the transfer of Chongqing Kang Wei stake. At the same time, Hou Yong Chairman also expressed the management in the vaccine industrialization process of the difficulties: 9 years of investment finally "keep cloud open See Sunrise", should celebrate. But my colleagues and I, while happy, feel more pressure, that is, how to quickly make the vaccine industry, the research results into productivity.　　At the same time, as far as possible to ensure that Yueyang hing long smooth development, do not suffer from the big ups and downs and fluctuations. The Chairman said, "In the past few years, because of our lack of bio-pharmaceutical enterprises in the construction, production, sales, management experience, lack of sufficient awareness of risk control and grasp, in the decision of the hesitates has made the industrialization of vaccines slow." Therefore, the introduction of strategic investors is entirely out of speeding up the process of industrialization, improve the competitiveness of enterprises, to prevent enterprise risk.